Skip to main content

Post-IPO Equity Therapeutics Companies

Explore 204 therapeutics startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
204
Total Funding
$3.3B
Avg Funding
$132.8M
Cities
21

Export 204 Post-IPO Equity Therapeutics Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
San Diego, United States
$632.5M
raised

Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.

Feb 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$125.0M
raised

2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Wayne, United States
$200.0M
raised

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$150.0M
raised

Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$150.0M
raised

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Seattle, United States
$175.0M
raised

Perspective Therapeutics focuses on advancing cancer treatments employing radiation, radiopharmaceuticals, and imaging technology.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Gaithersburg, United States
$3.7M
raised

NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.

Feb 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Carlsbad, United States
$200.0M
raised

Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.

Feb 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Mclean, United States
$1.2M
raised

Greenbrook provides Transcranial Magnetic Stimulation (TMS) therapy for individuals with treatment-resistant depression.

Feb 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$400.0M
raised

Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Tarpon Springs, United States
$3.3M
raised

A clinical-stage biopharmaceutical company identifying and developing therapeutics for the treatment of fungal and bacterial infections.

Feb 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Red Bank, United States
$35.0M
raised

Provention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing, and commercializing novel therapeutics.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Lund, Sweden
$1.4M
raised

Carbiotix is a pre-clinical stage therapeutics company focusing on low-cost gut health testing and microbiome modulators.

Feb 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$4.5M
raised

Numinus utilizes psychedelic-assisted psychotherapy methods to bring holistic healthcare to patients.

Feb 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Redwood City, United States
$50.1M
raised

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Waltham, United States
$40.0M
raised

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$50.0M
raised

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Carlton South, Australia
$5.0M
raised

RadioPharm Theranostics is a platform of radiopharmaceutical and nuclear medicine products for diagnostic and therapeutic uses.

Jan 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Basel, Switzerland
$300.0M
raised

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Lexington, United States
$140.0M
raised

Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Boston, United States
$350.0M
raised

Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Princeton, United States
$3.9M
raised

Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$125.0M
raised

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.

Dec 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Sydney, Australia
$1.9M
raised

CMT focuses on the development and commercialization of regenerative therapies derived from novel processed human platelets.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$172.5M
raised

Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 126 to 150 of 204 companies

Ready to Connect with Post-IPO Equity Therapeutics Startups?

Get verified founder emails, funding details, and company data for 204 post-ipo equity therapeutics companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

204 Therapeutics Post-IPO Equity Startups (September 2026) — Page 6 | VCBacked